Medpace Faces Class Action Over Alleged Misleading Book-to-Bill Claims
Class action lawsuit filed against $MDPC alleging executives overstated book-to-bill ratio at approximately 1.15 despite contrary internal data from April 2025 to February 2026.
MEDPsecurities fraudclass action lawsuit